Paper37595040
FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer.
Liu Y and 12 others. Sci Adv, 2023. Cited by 52 papers, by iCite.
Cite this record
ConductScience Library. FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer. Papers, record 37595040. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37595040
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Chromatin | Major topic |
| Humans | |
| Binding Sites | |
| Epigenomics | |
| Microfilament Proteins | |
| Hepatocyte Nuclear Factor 3-alpha |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 42886814 | Erratum for the Research Article "FOXA1 O-GlcNAcylation-mediated transcriptional switch governs metastasis capacity in breast cancer". | https://conductscience.org/library/papers/42886814 |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 29548027 | Functional crosstalk among oxidative stress and O-GlcNAc signaling pathways. | Glycobiology | 2018 | https://conductscience.org/library/papers/29548027 | PubMed |
| 2 | 33916244 | O-GlcNAcylation and O-GlcNAc Cycling Regulate Gene Transcription: Emerging Roles in Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33916244 | PubMed |
| 3 | 33827814 | Posttranslational regulation of FOXA1 by Polycomb and BUB3/USP7 deubiquitin complex in prostate cancer. | Sci Adv | 2021 | https://conductscience.org/library/papers/33827814 | PubMed |
| 4 | 30793308 | Resistance to bortezomib in breast cancer cells that downregulate Bim through FOXA1 O-GlcNAcylation. | J Cell Physiol | 2019 | https://conductscience.org/library/papers/30793308 | PubMed |
| 5 | 30819139 | The prognostic relevance of FOXA1 and Nestin expression in breast cancer metastases: a retrospective study of 164 cases during a 10-year period (2004-2014). | BMC Cancer | 2019 | https://conductscience.org/library/papers/30819139 | PubMed |
| 6 | 19897491 | Stable chromatin binding prevents FoxA acetylation, preserving FoxA chromatin remodeling. | J Biol Chem | 2010 | https://conductscience.org/library/papers/19897491 | PubMed |
| 7 | 32946061 | Pioneer of prostate cancer: past, present and the future of FOXA1. | Protein Cell | 2021 | https://conductscience.org/library/papers/32946061 | PubMed |
| 8 | 26417028 | Comparative Proteomics of Tumor and Paired Normal Breast Tissue Highlights Potential Biomarkers in Breast Cancer. | Cancer Genomics Proteomics | 2015 | https://conductscience.org/library/papers/26417028 | PubMed |
| 9 | 28455227 | Suppression of OGT by microRNA24 reduces FOXA1 stability and prevents breast cancer cells invasion. | Biochem Biophys Res Commun | 2017 | https://conductscience.org/library/papers/28455227 | PubMed |
| 10 | 27500525 | Nucleation of DNA repair factors by FOXA1 links DNA demethylation to transcriptional pioneering. | Nat Genet | 2016 | https://conductscience.org/library/papers/27500525 | PubMed |
| 11 | 34850111 | A set of accessible enhancers enables the initial response of breast cancer cells to physiological progestin concentrations. | Nucleic Acids Res | 2021 | https://conductscience.org/library/papers/34850111 | PubMed |
| 12 | 34019948 | O-GlcNAc modification regulates MTA1 transcriptional activity during breast cancer cell genotoxic adaptation. | Biochim Biophys Acta Gen Subj | 2021 | https://conductscience.org/library/papers/34019948 | PubMed |
| 13 | 24927503 | Genome-wide binding of MBD2 reveals strong preference for highly methylated loci. | PLoS One | 2014 | https://conductscience.org/library/papers/24927503 | PubMed |
| 14 | 36230619 | FOXA1 in Breast Cancer: A Luminal Marker with Promising Prognostic and Predictive Impact. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230619 | PubMed |
| 15 | 31826955 | FOXA1 upregulation promotes enhancer and transcriptional reprogramming in endocrine-resistant breast cancer. | Proc Natl Acad Sci U S A | 2019 | https://conductscience.org/library/papers/31826955 | PubMed |
| 16 | 34680352 | FOXA1: A Pioneer of Nuclear Receptor Action in Breast Cancer. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34680352 | PubMed |
| 17 | 12829800 | Repeated observation of breast tumor subtypes in independent gene expression data sets. | Proc Natl Acad Sci U S A | 2003 | https://conductscience.org/library/papers/12829800 | PubMed |
| 18 | 11823860 | Gene expression profiling predicts clinical outcome of breast cancer. | Nature | 2002 | https://conductscience.org/library/papers/11823860 | PubMed |
| 19 | 30371817 | SEdb: a comprehensive human super-enhancer database. | Nucleic Acids Res | 2019 | https://conductscience.org/library/papers/30371817 | PubMed |
| 20 | 27883218 | Tyrosine Phosphorylation of the Pioneer Transcription Factor FoxA1 Promotes Activation of Estrogen Signaling. | J Cell Biochem | 2017 | https://conductscience.org/library/papers/27883218 | PubMed |
Cited by40
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42839907 | MeCP2 functions as a DNA methylation reader in immune homeostasis and cancer. | Front Epigenet Epigenom | 2026 | https://conductscience.org/library/papers/42839907 | PubMed |
| 42793317 | Mechanical Unloading Inhibits Osteoblast Differentiation via Downregulation of OGT-Mediated O-GlcNAcylation. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42793317 | PubMed |
| 42351196 | Transcription factor FOXA1 suppresses ferroptosis of cervical cancer cells by upregulating SLC7A11 expression. | Cell Div | 2026 | https://conductscience.org/library/papers/42351196 | PubMed |
| 42251269 | Ultrasound-based multiregional radiomics nomogram for predicting recurrence in HER2-positive breast cancer. | BMC Med Imaging | 2026 | https://conductscience.org/library/papers/42251269 | PubMed |
| 42245745 | Loss of EPB41L3: a common molecular link in the tumorigenesis of neurofibromatosis types 1 and 2. | Front Oncol | 2026 | https://conductscience.org/library/papers/42245745 | PubMed |
| 42120607 | Integrative transcriptomic analysis reveals novel targets for personalized medicine across seven metastatic breast cancer subtypes. | Sci Rep | 2026 | https://conductscience.org/library/papers/42120607 | PubMed |
| 42082461 | Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions. | Signal Transduct Target Ther | 2026 | https://conductscience.org/library/papers/42082461 | PubMed |
| 41918590 | SULF1 and EPB41L3: Potential Biomarkers of Acute Myocardial Infarction and the Vascular Inflammatory Milieu. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/41918590 | PubMed |
| 41800247 | O-GlcNAcylation stabilizes RSK4 by antagonizing GSK3β-mediated phosphorylation to enhance radioresistance in esophageal squamous cell carcinoma. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/41800247 | PubMed |
| 41738032 | Alterations in AR-FOXA1 signaling in prostate cancer progression and therapeutic resistance. | J Natl Cancer Cent | 2026 | https://conductscience.org/library/papers/41738032 | PubMed |
| 41655690 | Decoding the regulatory code: O-GlcNAcylation in epithelial-mesenchymal transition (EMT). | J Biol Chem | 2026 | https://conductscience.org/library/papers/41655690 | PubMed |
| 41629644 | POM121 O-GlcNAcylation facilitates bone metastasis in non-small cell lung cancer through enhanced c-MYC nuclear import and ECM reprogramming. | Oncogene | 2026 | https://conductscience.org/library/papers/41629644 | PubMed |
| 41535889 | O-GlcNAcylation of NONO mediates alternative splicing of SETMAR and facilitates NHEJ repair. | Genome Biol | 2026 | https://conductscience.org/library/papers/41535889 | PubMed |
| 41507163 | Time-resolved multiomics profiling reveals chromatin O-GlcNAc modification promotes senescence-associated transcriptional program. | Nat Commun | 2026 | https://conductscience.org/library/papers/41507163 | PubMed |
| 41485575 | OGT regulates histone demethylation and alleviates osteoarthritis progression by O-GlcNAcylation of KDM6B. | J Adv Res | 2026 | https://conductscience.org/library/papers/41485575 | PubMed |
| 41389271 | VNN1, upregulated by FOXA1, suppresses osteogenic differentiation and promotes inflammation in LPS-induced periodontal ligament stem cells. | Odontology | 2026 | https://conductscience.org/library/papers/41389271 | PubMed |
| 41244923 | Dual oncogenic role of RNF220 in AML: linking metabolic rewiring to cell proliferation and immune evasion. | Front Oncol | 2025 | https://conductscience.org/library/papers/41244923 | PubMed |
| 40825935 | A phosphorylation switch in the Mediator MED15 controls cellular senescence and cognitive decline. | Cell Discov | 2025 | https://conductscience.org/library/papers/40825935 | PubMed |
| 40601247 | Novel insights into lncRNAs as key regulators of post-translational modifications in cancer: mechanisms and therapeutic potential. | Cell Oncol (Dordr) | 2025 | https://conductscience.org/library/papers/40601247 | PubMed |
| 40596516 | DNA probe pulldown screening uncovers O-GlcNAcylation modulation of transcription factor DNA interactions. | Sci Rep | 2025 | https://conductscience.org/library/papers/40596516 | PubMed |
Genes9
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| COL9A2 | 1298 | PubTator's text mining | https://conductscience.org/library/genes/1298 | NCBI Gene |
| EPB41L3 | 23136 | PubTator's text mining | https://conductscience.org/library/genes/23136 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| F3 | 2152 | PubTator's text mining | https://conductscience.org/library/genes/2152 | NCBI Gene |
| FOXA1 | 3169 | PubTator's text mining | https://conductscience.org/library/genes/3169 | NCBI Gene |
| GFPT1 | 2673 | PubTator's text mining | https://conductscience.org/library/genes/2673 | NCBI Gene |
| MECP2 | 4204 | PubTator's text mining | https://conductscience.org/library/genes/4204 | NCBI Gene |
| OGA | 10724 | PubTator's text mining | https://conductscience.org/library/genes/10724 | NCBI Gene |
| OGT | 8473 | PubTator's text mining | https://conductscience.org/library/genes/8473 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37595040
GET https://conductscience.org/api/papers/v1/37595040/references?page=2